What Happened?
Baltimore, MD-based Personal-Genome-Diagnostics Appointed Megan Bailey as Chief Executive Officer
About the Company
Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. Our expertise in advanced cancer genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. We specialize in high-throughput next-generation sequencing, proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive approaches in cancer. PGDx was founded in 2010 by Luis Diaz and Victor Velculescu to help bring novel diagnostic approaches to patients with cancer. They are internationally recognized leaders in cancer genomics who have extensive experience in the application of innovative genomic technologies for drug development and clinical practice.
About the Person
Megan Bailey is Chief Executive Officer at Personal Genome Diagnostics. Previously, Megan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile